Abstract
Clinical Outcomes Of Patients With Primary Or Metastatic Liver Tumors Treated With Dose-Escalated Yttrium-90 (Y-90) Transarterial Radioembolization (TARE)
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Radiation Oncology, Biology, Physics
Paper Title
Journal
Date
